ZA200110386B - Stable xylometazoline and oxymetazoline solution. - Google Patents

Stable xylometazoline and oxymetazoline solution. Download PDF

Info

Publication number
ZA200110386B
ZA200110386B ZA200110386A ZA200110386A ZA200110386B ZA 200110386 B ZA200110386 B ZA 200110386B ZA 200110386 A ZA200110386 A ZA 200110386A ZA 200110386 A ZA200110386 A ZA 200110386A ZA 200110386 B ZA200110386 B ZA 200110386B
Authority
ZA
South Africa
Prior art keywords
formulation according
weight
formulation
solution
active substance
Prior art date
Application number
ZA200110386A
Other languages
English (en)
Inventor
Maerz Frieder Ulrich
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23322017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200110386(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200110386B publication Critical patent/ZA200110386B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
ZA200110386A 1999-06-22 2001-12-19 Stable xylometazoline and oxymetazoline solution. ZA200110386B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33778999A 1999-06-22 1999-06-22

Publications (1)

Publication Number Publication Date
ZA200110386B true ZA200110386B (en) 2003-04-22

Family

ID=23322017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200110386A ZA200110386B (en) 1999-06-22 2001-12-19 Stable xylometazoline and oxymetazoline solution.

Country Status (22)

Country Link
US (2) US20040191177A1 (es)
EP (1) EP1194145B1 (es)
JP (1) JP2003502361A (es)
KR (1) KR20020012001A (es)
CN (1) CN1164271C (es)
AT (1) ATE232099T1 (es)
AU (1) AU765736B2 (es)
BR (1) BR0011950A (es)
CA (1) CA2376121C (es)
CZ (1) CZ295595B6 (es)
DE (1) DE50001217D1 (es)
EA (1) EA003329B1 (es)
ES (1) ES2188563T3 (es)
HK (1) HK1045945B (es)
HU (1) HUP0201700A3 (es)
IL (1) IL147023A0 (es)
MX (1) MXPA01012912A (es)
PL (1) PL197542B1 (es)
PT (1) PT1194145E (es)
TR (1) TR200103694T2 (es)
WO (1) WO2000078297A2 (es)
ZA (1) ZA200110386B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1446119B1 (en) 2001-09-18 2006-03-01 Nycomed Danmark ApS Compositions comprising ipatropium and xylometazoline for treatment of the common cold
CA2489528A1 (en) * 2002-06-20 2003-12-31 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
AU2007243334A1 (en) * 2006-04-26 2007-11-08 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
PL3236933T3 (pl) 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19542959C1 (de) * 1995-11-17 1996-10-24 Ursatec Verpackung Gmbh Vor Kontamination schützende Abgabevorrichtung für Fluide
ES2190477T3 (es) * 1995-11-17 2003-08-01 Ursatec Verpackung Gmbh Dispensador de fluidos diseñado para proteger el contenido de la contaminacion.
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions

Also Published As

Publication number Publication date
CZ295595B6 (cs) 2005-08-17
DE50001217D1 (de) 2003-03-13
EP1194145B1 (de) 2003-02-05
CZ20014568A3 (cs) 2002-03-13
CN1361689A (zh) 2002-07-31
ES2188563T3 (es) 2003-07-01
WO2000078297A3 (de) 2001-03-01
JP2003502361A (ja) 2003-01-21
HK1045945B (zh) 2005-01-28
TR200103694T2 (tr) 2002-04-22
MXPA01012912A (es) 2002-09-18
PT1194145E (pt) 2003-06-30
ATE232099T1 (de) 2003-02-15
AU6150600A (en) 2001-01-09
KR20020012001A (ko) 2002-02-09
US20040191177A1 (en) 2004-09-30
PL352354A1 (en) 2003-08-11
EA003329B1 (ru) 2003-04-24
CA2376121C (en) 2008-06-10
CN1164271C (zh) 2004-09-01
PL197542B1 (pl) 2008-04-30
HUP0201700A3 (en) 2003-02-28
US20080011293A1 (en) 2008-01-17
AU765736B2 (en) 2003-09-25
HK1045945A1 (en) 2002-12-20
BR0011950A (pt) 2002-03-12
HUP0201700A2 (hu) 2002-12-28
WO2000078297A2 (de) 2000-12-28
CA2376121A1 (en) 2000-12-28
EA200200042A1 (ru) 2002-06-27
EP1194145A2 (de) 2002-04-10
IL147023A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
US20080011293A1 (en) Stable Xylometazoline and Oxymetazoline Solution
US8426474B2 (en) Antimicrobial wash and carrier solutions and uses thereof
CN102387793B (zh) 包括银离子源和薄荷醇的抗菌组合物及其用途
US20080070908A1 (en) Compositions including antibiotics and methods for using same
US20080146553A1 (en) Antibiotic compostions and methods for using same
CN101578045A (zh) 抗微生物组合物
JP2022116141A (ja) エモリエント性の局所消毒剤
US20190076345A9 (en) Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US20100331421A1 (en) Disinfectant and/or bactericidal aqueous compositions
US11331289B2 (en) Antimicrobial composition
WO2023019033A1 (en) High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
US20070041866A1 (en) Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
EP2138171A1 (en) Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis
US5336508A (en) Preservative for pharmaceutical products
JP2020529471A (ja) 微生物のコロニー形成を抑制するための置換トラン
US20230414570A1 (en) Compositions against candida infections
KR101350442B1 (ko) 클로르헥시딘을 함유하는 안정한 수용성 살균방부제 조성물
JP2003292402A (ja) 殺菌消毒用組成物